Clinical Trials Sponsored by Nymox Corporation

Total 6480 results

Adimmune Corporation

Completed

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old

Influenza
Incyte Corporation

Terminated

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
NeuroVista Corporation

Terminated

Seizure Advisory System Feasibility Study

Epilepsy

Australia
Omeros Corporation

Completed

Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstruction

Knee Injuries

United States, Canada
Omeros Corporation

Completed

Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstruction

Knee Injuries

United States, Canada
Yuhan Corporation

Completed

Food Effect on Pharmacokinetics of YH4808 in Healthy Male Subjects

Healthy

Korea, Republic of
Adimmune Corporation

Completed

Immunogenicity and Safety of AdimFlu-S 2011-2012 in Non-Elderly Adult and Elderly Subjects

Influenza

Taiwan
Vidacare Corporation

Completed

Observation of Intraosseous Vascular Access in the Emergency Department

Patients Requiring Urgent Vascular Access

United States
Mannkind Corporation

Completed

Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin

Healthy
Mannkind Corporation

Completed

A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics

Diabetes Mellitus | Asthma

United Kingdom
Yuhan Corporation

Completed

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

Hypertension | Hyperlipidemia

Korea, Republic of
Cordis Corporation

Completed

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary | Peripheral Arteriosclerosis

United States
Mannkind Corporation

Terminated

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

Stage IV Melanoma | Stage III Melanoma

United States
Cordis Corporation

Completed

ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU (ECLIPSE)

Coronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary

Germany
Revalesio Corporation

Completed

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Myocardial Infarct

United States
VaxInnate Corporation

Completed

Comparative Safety and Immunogenicity of 1.0 µg Intramuscular (i.m.) and 2.0 µg Subcutaneous (s.c.) Dosing With VAX102 (M2e-flagellin) Universal Influenza Vaccine in Healthy Adults

Influenza

United States
Seikagaku Corporation

Completed

Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee

Osteoarthritis of the Knee

United States
Yuhan Corporation

Completed

Randomized, Open-label, Parallel Study to Evaluate the Pharmacokinetic Characteristics of Pregabalin According to Different Controlled Released Formulations in Healthy Male Subjects

Healthy

Korea, Republic of
EpiCept Corporation

Completed

A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)

Neuropathy | Nerve Pain | Post Herpetic Neuralgia | PHN

India
VIRxSYS Corporation

Active, not recruiting

A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial (Rollover)

HIV Infections

United States
Cordis Corporation

Terminated

French Post-Marketing Surveillance Survey (FR E-REGISTRY)

Coronary Artery Disease
Magnetecs Corporation

Unknown

Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping (RICTAM)

Tachycardia, Ventricular | Tachycardia, Supraventricular

Spain
AmpliMed Corporation

Completed

Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

United States
Guidant Corporation

Completed

PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)

Acute Myocardial Infarction

Netherlands
Guidant Corporation

Completed

Long Term Integrity Follow-up Evaluation (LEAD LIFE)

Sudden Cardiac Death
Mannkind Corporation

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.

Advanced Melanoma | Stage III and IV Melanoma

United States
Benesis Corporation

Completed

Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

Japan
NovaRx Corporation

Completed

Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer

Carcinoma, Bronchogenic | Lung Neoplasm

United States
Cordis Corporation

Completed

A Study of the Presillion Stent in de Novo Coronary Lesions (PRESILLION)

Coronary Artery Disease

Belgium
Cordis Corporation

Completed

NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Cordis Corporation

Completed

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial (DESSERT)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

The Study of the Crushing Technique Application Using SES in Coronary Bifurcations. (CACTUS)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)

Coronary Artery Disease

United States
MorePharma Corporation

Completed

Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation

Premature Ejaculation

Mexico
Cordis Corporation

Completed

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Coronary Artery Disease

United States
Mannkind Corporation

Completed

Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

Diabetes Type 2

Russian Federation
Cordis Corporation

Completed

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

Coronary Stenosis
AmpliMed Corporation

Completed

Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients

Multiple Myeloma

United States
Mannkind Corporation

Completed

Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes

Diabetes Type 2

United States
MiCardia Corporation

Unknown

Dynamic Annuloplasty System With Activation for the Treatment of Mitral Regurgitation (DYANA)

Mitral Valve Regurgitation

Germany, Netherlands, Canada
Boneca Corporation

Completed

BNCT to Treat Glioma That Has Progressed Following Radiotherapy

Glioblastoma | Anaplastic Astrocytoma

Finland
Pulmonx Corporation

Completed

Safety and Feasibility Study of the Chartis System

Bronchoscopy

Germany
PhytoHealth Corporation

Completed

A Phase II Clinical Study of PDC-748 in Patients With Acute Cough

Acute Cough

Taiwan
Cordis Corporation

Terminated

Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)

Peripheral Vascular Diseases

United States, China, Malaysia, India, Singapore
Cordis Corporation

Completed

The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions. (C-SIRIUS)

Coronary Artery Disease
Cordis Corporation

Completed

The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions. (SVELTE)

Coronary Artery Disease

Switzerland
Cordis Corporation

Completed

The Initial Double-Blind Drug-Eluting Stent vs Bare-Metal Stent Study. (RAVEL)

Coronary Artery Disease

France
Glaukos Corporation

Completed

A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects

Open-Angle Glaucoma

Spain, Germany, Italy, Netherlands
Neurogen Corporation

Terminated

Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs

Primary Insomnia

United States

3

Subscribe